SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Shares Sold by Jane Street Group LLC

Jane Street Group LLC reduced its stake in shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) by 90.0% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,839 shares of the company’s stock after selling 52,269 shares during the period. Jane Street Group LLC owned 0.12% of SPDR S&P Pharmaceuticals ETF worth $259,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. AlphaMark Advisors LLC raised its position in SPDR S&P Pharmaceuticals ETF by 5.9% in the third quarter. AlphaMark Advisors LLC now owns 6,225 shares of the company’s stock valued at $276,000 after purchasing an additional 348 shares during the period. Commonwealth Equity Services LLC raised its position in SPDR S&P Pharmaceuticals ETF by 8.9% in the second quarter. Commonwealth Equity Services LLC now owns 7,364 shares of the company’s stock valued at $293,000 after purchasing an additional 602 shares during the period. Stifel Financial Corp purchased a new stake in SPDR S&P Pharmaceuticals ETF in the third quarter valued at approximately $337,000. Rockport Wealth LLC purchased a new stake in shares of SPDR S&P Pharmaceuticals ETF during the second quarter worth $1,813,000. Finally, First Citizens Bank & Trust Co. increased its position in shares of SPDR S&P Pharmaceuticals ETF by 9.5% during the third quarter. First Citizens Bank & Trust Co. now owns 72,053 shares of the company’s stock worth $3,196,000 after acquiring an additional 6,227 shares during the period.

SPDR S&P Pharmaceuticals ETF Trading Down 0.2 %

Shares of XPH stock opened at $42.72 on Friday. The firm has a fifty day moving average price of $44.96 and a 200 day moving average price of $43.93. The company has a market cap of $207.19 million, a P/E ratio of 14.39 and a beta of 0.87. SPDR S&P Pharmaceuticals ETF has a 12 month low of $38.88 and a 12 month high of $48.76.

SPDR S&P Pharmaceuticals ETF Company Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.